You finally have investor interest. A couple of angels like the idea, one says “We usually do SAFEs,” another asks if you’re open to a convertible note, and suddenly you’re deep in legal blog posts at ...

For many early-stage startups, choosing between a convertible note and a SAFE (Simple Agreement for Future Equity) is one of the first critical legal and strategic financing decisions. While both ...

MicroStrategy is using convertible notes in a unique way to raise funds and buy more bitcoin. Sophisticated investors love these bonds because of the volatility allows for profitable trading ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...

In the world of early stage investing, there exists a range of structures from the most founder friendly to the most investor friendly. The most investor-friendly structure involves some type of a ...

WATSONVILLE, Calif.--(BUSINESS WIRE)--Granite Construction Incorporated (NYSE: GVA) (“Granite”) today announced the pricing of its previously announced offering of $325 million aggregate principal ...

GameStop is back in the news with another wave of shareholder dilution. The company announced plans to issue $1.3 billion of convertible senior notes with an additonal $200 million on the table as ...

LOS ANGELES, Dec. 3, 2024 /PRNewswire/ -- Live Nation Entertainment, Inc. (NYSE: LYV) (the "company") today announced that it priced its previously announced offering of $1.0 billion in aggregate ...

Akamai Technologies (AKAM) announced on Monday that it proposes to offer $1.3B in aggregate principal amount of 0% convertible senior notes due 2030 and $1.3B in aggregate principal amount of 0% ...

LAS VEGAS, Dec. 13, 2024 /PRNewswire/ -- CleanSpark, Inc. (Nasdaq: CLSK), America's Bitcoin Miner® ("CleanSpark" or the "Company"), today announced the pricing of its offering of $550 million ...

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for ...